Pet Diabetes Care Devices Market Outlook 2025-2034: Market Share, and Growth Analysis

The Pet Diabetes Care Devices Market is valued at USD 3.3 billion in 2025 and is projected to grow at a CAGR of 8.4% to reach USD 6.8 billion by 2034.

Pet Diabetes Care Devices Market Overview

The pet diabetes care devices market is growing rapidly as the prevalence of diabetes among pets, particularly dogs and cats, continues to rise. Diabetes in pets is a chronic condition that requires ongoing monitoring and management, much like in humans. Pet diabetes care devices, including glucose monitoring systems, insulin delivery devices, and continuous glucose monitoring (CGM) sensors, play a crucial role in ensuring proper disease management. With pet owners increasingly prioritizing their pets’ health and well-being, the demand for accurate, easy-to-use, and efficient diabetes care devices has surged. Advances in veterinary medicine and digital health solutions have also contributed to market expansion, providing pet owners with real-time data on their pet’s glucose levels and insulin requirements. The rising adoption of wearable diabetes monitoring devices, telemedicine consultations, and personalized treatment plans has further revolutionized the pet diabetes care landscape. As awareness about pet diabetes increases, veterinary professionals and pet care brands are working together to improve early diagnosis and treatment accessibility, making diabetes management more effective and convenient for pet owners worldwide.

The pet diabetes care devices market has seen significant advancements in technology and accessibility. One of the most notable developments is the rise of continuous glucose monitoring (CGM) devices, which allow pet owners to track glucose levels in real time without frequent blood sampling. These non-invasive and wearable devices provide more accurate and stress-free monitoring compared to traditional glucose meters. Additionally, smart insulin pens and automated insulin pumps designed for pets have gained traction, improving dosage accuracy and making insulin administration easier for pet owners. Telehealth and mobile app integrations have also played a crucial role in diabetes care, enabling remote monitoring and real-time data sharing between pet owners and veterinarians. The expansion of pet insurance policies covering diabetes treatment has further encouraged owners to invest in advanced diabetes care solutions. Moreover, increased consumer awareness about obesity-related diabetes in pets has led to a surge in demand for dietary management tools and prescription-based diabetic pet foods. The pet healthcare industry in 2024 is focused on making diabetes care more accessible, reducing the burden on pet owners, and enhancing the quality of life for diabetic pets.

The pet diabetes care devices market is expected to evolve further with continued innovation and broader adoption of digital health solutions. AI-powered diabetes management systems, capable of predicting fluctuations in glucose levels and recommending adjustments to diet and insulin dosage, are anticipated to become more prevalent. Advancements in nanotechnology and biosensors may lead to the development of ultra-sensitive, painless glucose monitoring patches that eliminate the need for frequent blood draws. The integration of smart pet collars with glucose monitoring capabilities is also expected to gain traction, allowing for seamless, real-time health tracking. Additionally, more research into gene therapy and regenerative medicine may offer new treatment pathways for managing diabetes in pets. As veterinary healthcare continues to advance, collaborations between veterinary clinics, tech companies, and pet food manufacturers will drive the development of more holistic diabetes management solutions. The market will also witness an increasing focus on preventative care, with specialized pet diets, weight management programs, and early screening tools becoming standard practice. With these advancements, pet diabetes management is set to become more precise, accessible, and efficient, improving outcomes for pets and their owners alike.

Key Insights: Pet Diabetes Care Devices Market

• Adoption of Continuous Glucose Monitoring (CGM) Devices: CGM technology is becoming more popular, allowing pet owners to track glucose levels in real time without frequent blood sampling.
• Integration of AI in Diabetes Management: AI-powered platforms are helping analyze glucose patterns, predict fluctuations, and provide personalized insulin and diet recommendations.
• Expansion of Smart Insulin Delivery Systems: The development of smart insulin pens and automated insulin pumps is improving dosage accuracy and convenience for pet owners.
• Telehealth and Mobile App Integration: Remote monitoring, virtual consultations, and real-time data sharing between pet owners and veterinarians are transforming diabetes care.
• Focus on Preventative Care and Obesity Management: With obesity being a major risk factor for diabetes, there is growing demand for prescription-based diabetic pet foods and weight management programs.
• Rising Prevalence of Diabetes in Pets: The increasing incidence of diabetes among dogs and cats is driving demand for advanced monitoring and treatment solutions.
• Technological Advancements in Veterinary Healthcare: Innovations in glucose monitoring, insulin delivery, and digital health tools are making diabetes management more precise and effective.
• Increasing Pet Owner Awareness and Willingness to Invest in Care: More pet owners are prioritizing preventive and long-term healthcare solutions, leading to higher adoption of diabetes management devices.
• Growing Adoption of Pet Insurance Covering Diabetes Treatment: More pet insurance providers are covering diabetes-related expenses, making advanced care more accessible to pet owners.
• High Cost of Advanced Diabetes Care Devices: The affordability of CGM devices, smart insulin pumps, and AI-powered monitoring systems remains a challenge, limiting adoption in cost-sensitive markets.

Pet Diabetes Care Devices Market Segmentation

By Animal Type

• Dogs
• Cats
• Horses

By Device

• Glucose Monitoring Devices
• Insulin Delivery Devices

By End Users

• Homecare
• Veterinary Hospitals
• Others End Users

Key Companies Analysed

• Allison Medical Inc.
• Zoetis Inc.
• Becton Dickinson and Company
• Boehringer Ingelheim Vetmedica Inc.
• Henry Schein Animal Health
• Apotex Inc.
• Merck Co. Inc.
• Trividia Health Inc.
• UltiMed Inc.
• ACON Laboratories Inc.
• i-SENS Inc.
• TaiDoc Technology Corporation
• Abbott Laboratories
• Medtronic Inc.
• Novo Nordisk AS
• Covetrus AG
• Med Trust Co.
• F. Hoffmann-La Roche AG
• Sanofi SA
• Eli Lilly and Company
• Novartis AG
• Johnson & Johnson Services Inc.
• Bayer AG
• Terumo Corporation
• Insulet Corporation
• Medline Industries Inc.
• Nipro Corporation
• Senseonics Holdings Inc.
• Ypsomed Holding AG.

Pet Diabetes Care Devices Market Analytics

The report employs rigorous tools, including Porter’s Five Forces, value chain mapping, and scenario-based modeling, to assess supply-demand dynamics. Cross-sector influences from parent, derived, and substitute markets are evaluated to identify risks and opportunities. Trade and pricing analytics provide an up-to-date view of international flows, including leading exporters, importers, and regional price trends.

Macroeconomic indicators, policy frameworks such as carbon pricing and energy security strategies, and evolving consumer behavior are considered in forecasting scenarios. Recent deal flows, partnerships, and technology innovations are incorporated to assess their impact on future market performance.

Pet Diabetes Care Devices Market Competitive Intelligence

The competitive landscape is mapped through proprietary frameworks, profiling leading companies with details on business models, product portfolios, financial performance, and strategic initiatives. Key developments such as mergers & acquisitions, technology collaborations, investment inflows, and regional expansions are analyzed for their competitive impact. The report also identifies emerging players and innovative startups contributing to market disruption.

Regional insights highlight the most promising investment destinations, regulatory landscapes, and evolving partnerships across energy and industrial corridors.

Countries Covered

• North America - Pet Diabetes Care Devices market data and outlook to 2034
  • United States
  • Canada
  • Mexico
  
  
• Europe - Pet Diabetes Care Devices market data and outlook to 2034
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • BeNeLux
  • Russia
  • Sweden
  
  
• Asia-Pacific - Pet Diabetes Care Devices market data and outlook to 2034
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Malaysia
  • Vietnam
  
  
• Middle East and Africa - Pet Diabetes Care Devices market data and outlook to 2034
  • Saudi Arabia
  • South Africa
  • Iran
  • UAE
  • Egypt
  
  
• South and Central America - Pet Diabetes Care Devices market data and outlook to 2034
  • Brazil
  • Argentina
  • Chile
  • Peru

Research Methodology

This study combines primary inputs from industry experts across the Pet Diabetes Care Devices value chain with secondary data from associations, government publications, trade databases, and company disclosures. Proprietary modeling techniques, including data triangulation, statistical correlation, and scenario planning, are applied to deliver reliable market sizing and forecasting.

Key Questions Addressed

• What is the current and forecast market size of the Pet Diabetes Care Devices industry at global, regional, and country levels?
• Which types, applications, and technologies present the highest growth potential?
• How are supply chains adapting to geopolitical and economic shocks?
• What role do policy frameworks, trade flows, and sustainability targets play in shaping demand?
• Who are the leading players, and how are their strategies evolving in the face of global uncertainty?
• Which regional “hotspots” and customer segments will outpace the market, and what go-to-market and partnership models best support entry and expansion?
• Where are the most investable opportunities - across technology roadmaps, sustainability-linked innovation, and M&A - and what is the best segment to invest over the next 3-5 years?

Your Key Takeaways from the Pet Diabetes Care Devices Market Report

• Global Pet Diabetes Care Devices market size and growth projections (CAGR), 2024-2034
• Impact of Russia-Ukraine, Israel-Palestine, and Hamas conflicts on Pet Diabetes Care Devices trade, costs, and supply chains
• Pet Diabetes Care Devices market size, share, and outlook across 5 regions and 27 countries, 2023-2034
• Pet Diabetes Care Devices market size, CAGR, and market share of key products, applications, and end-user verticals, 2023-2034
• Short- and long-term Pet Diabetes Care Devices market trends, drivers, restraints, and opportunities
• Porter’s Five Forces analysis, technological developments, and Pet Diabetes Care Devices supply chain analysis
• Pet Diabetes Care Devices trade analysis, Pet Diabetes Care Devices market price analysis, and Pet Diabetes Care Devices supply/demand dynamics
• Profiles of 5 leading companies - overview, key strategies, financials, and products
• Latest Pet Diabetes Care Devices market news and developments

Additional Support

With the purchase of this report, you will receive:

• An updated PDF report and an MS Excel data workbook containing all market tables and figures for easy analysis.
• 7-day post-sale analyst support for clarifications and in-scope supplementary data, ensuring the deliverable aligns precisely with your requirements.
• Complimentary report update to incorporate the latest available data and the impact of recent market developments.

This product will be delivered within 1-3 business days.